EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Peeling back the layers of immunogenicity in Cas9-based genomic medicine

Virpi Stigzelius, Anna Lina Cavallo, Rakesh Kantilal Chandode, Roberto Nitsch

Molecular Therapy · 2025-10 · 33 (10) · 4714-4730

DOI: 10.1016/j.ymthe.2025.06.045 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Therapy, 2025-10. Verfasst von Virpi Stigzelius und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cell Therapy Safety, Clinical and Pharmacological Safety Sciences, AstraZeneca R&D, 431 83 Mölndal, Sweden; Drug Research Program, Faculty of Pharmac…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, Genetic Therapy, CRISPR-Associated Protein 9. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions, European Research Executive Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingGenetic TherapyCRISPR-Associated Protein 9GenomicsHumansAnimals

Stichwörter der Autor:innen

CRISPR-Cas9genetic diseasesgenomic medicinehost immune responseimmunogenicity

Substanzen

CRISPR-Associated Protein 9

Autor:innen und Institutionen

  • Cell Therapy Safety, Clinical and Pharmacological Safety Sciences, AstraZeneca R&D, 431 83 Mölndal, Sweden; Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.
  • Immune Analytics & CGT Dx Bioanalysis, Clinical Pharmacology and Safety Sciences, AstraZeneca R&D, 431 83 Mölndal, Sweden.
  • Immunology Safety, Safety Sciences, Clinical Pharmacology and Safety Sciences, AstraZeneca R&D, 431 83 Mölndal, Sweden.
  • Cell Therapy Safety, Clinical and Pharmacological Safety Sciences, AstraZeneca R&D, 431 83 Mölndal, Sweden. Electronic address: roberto.nitsch@astrazeneca.com.

Förderung

  • EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions
  • European Research Executive Agency

Zitieren

APA

Stigzelius, V., Cavallo, A. L., Chandode, R. K., & Nitsch, R. (2025). Peeling back the layers of immunogenicity in Cas9-based genomic medicine. Molecular Therapy, 33(10), 4714-4730. https://doi.org/10.1016/j.ymthe.2025.06.045

Vancouver

Stigzelius V, Cavallo AL, Chandode RK, Nitsch R. Peeling back the layers of immunogenicity in Cas9-based genomic medicine. Molecular Therapy. 2025;33(10):4714-4730. doi:10.1016/j.ymthe.2025.06.045

BibTeX
@article{Stigzelius2025,
  author = {Stigzelius, Virpi and Cavallo, Anna Lina and Chandode, Rakesh Kantilal and Nitsch, Roberto},
  title = {Peeling back the layers of immunogenicity in Cas9-based genomic medicine},
  journal = {Molecular Therapy},
  year = {2025},
  volume = {33},
  number = {10},
  pages = {4714--4730},
  doi = {10.1016/j.ymthe.2025.06.045}
}
Kostenlos starten →